Omics in allergy and asthma

J Allergy Clin Immunol. 2024 Oct 9:S0091-6749(24)01025-X. doi: 10.1016/j.jaci.2024.09.023. Online ahead of print.

Abstract

This review explores the transformative impact of omics technologies on allergy and asthma research in recent years, focusing on advancements in high-throughput technologies related to genomics and transcriptomics. In particular, the rapid spread of single-cell RNA sequencing has markedly advanced our understanding of the molecular pathology of allergic diseases. Furthermore, high-throughput genome sequencing has accelerated the discovery of monogenic disorders that were previously overlooked as ordinary intractable allergic diseases. We also introduce microbiomics, proteomics, lipidomics, and metabolomics, which are quickly growing areas of research interest, although many of their current findings remain inconclusive as solid evidence. By integrating these omics data, we will gain deeper insights into disease mechanisms, leading to the development of precision medicine approaches that promise to enhance treatment outcomes.

Keywords: Asthma; atopic dermatitis; chronic rhinosinusitis; genomics; single-cell RNA sequencing.

Publication types

  • Review